The WHO-Recommended Drug for Multi-Drug Resistant TB
Veloxin (Moxifloxacin) is a fluroquinolone, i.e., a broad-spectrum antibiotic that treats a variety of bacterial-resistant infections. It is particularly recommended by the American Thoracic Society and Infectious Disease Society for the treatment of multi-drug resistant tuberculosis (MDR-TB).
Veloxin has a high clinical success rate. It has excellent tissue penetration and is active against both gram-positive and gram-negative bacteria. It inhibits bacterial cell replication by inhibiting DNA gyrase (topoisomerase II) and topoisomerase IV – types of enzymes crucial for bacterial DNA replication.
Take Veloxin by mouth with or without food as directed by your pharmacist. The dosage and length of treatment are based on your medical condition and response to treatment.
- MDR-TB –once a day for 6 months (intensive phase) and 12-18 months (continuation phase)
- AECB – once a day for 5 consecutive days
- CAP – once a day for 10 consecutive days
- ABS – once a day for 7 consecutive days
Drink plenty of fluids while taking this drug unless your doctor tells you otherwise.
For the best effect, take this antibiotic at evenly spaced times. To help you remember, take this medication at the same time(s) every day.